Ocular/Otic 2017 Archive

Tier 1 products are covered with no authorization necessary

Tier 2 authorization criteria

• FDA approved diagnosis; AND
• A trial of one Tier-1 medication for a minimum of two weeks in the last 30 days that did not yield adequate relief of symptoms or resulted in intolerable adverse effects; OR
• A contraindication to all lower tiered medications

Tier 3 authorization criteria

• An FDA approved diagnosis; AND
• Recent trials of one Tier-1 medication and all available Tier-2 medications for a minimum of two weeks that did not yield adequate relief of symptoms or resulted in intolerable adverse effects; OR
• A contraindication to all lower tiered medications

Prior Authorization form

Tier 1

Tier 2

Tier 3

• ketotifen (Alaway®, Zaditor OTC®)
• cromolyn (Crolom®)

• azelastine (Optivar®)
• olopatadine (Patanol®)
• olopatadine hydrochloride (Pazeo™)

• pemirolast (Alamast®)
• nedocromil (Alocril®)
• lodoxamide (Alomide®)
• loteprednol (Alrex®)
• bepotastine (Bepreve®)
• epinastine (Elestat®)
• emadastine (Emadine®)
• alcaftadine (Lastacaft®)
• olopatadine (Pataday®)

Tier 1 products are covered with no authorization necessary

Tier 2 authorization criteria:

• Members must have adequate 14 day trial of at least two tier 1 medications, or
• Approval may be granted if there is a unique FDA approved indication not covered by tier 1 products or infection by organism not known to be covered by any of the tier 1 agents.
  
  Prior Authorization form  

Tier 1

Tier 2

Special PA

•ciprofloxacin (Cetraxal®)
•ciprofloxacin/fluocinolone (Otovel®)
•finafloxacin (Xtoro™)
•neomycin, polymyxin B, hydrocortisone (Cortisporin®, Pediotic®)
•ofloxacin (Floxin® Otic)

• acetic acid/HC (Acetasol® HC, VoSol® HC)

Tier 1 products are covered with no authorization necessary

Tier 2 authorization criteria

•  Documented trials of all Tier-1 ophthalmic NSAIDs (from different product lines) in the last 30 days that did not yield adequate relief of symptoms or resulted in intolerable adverse effects; OR  
• Contraindication to all lower tiered medications; OR 
• A unique indication for which the Tier-1 anti-inflammatories lack.  

 Prior Authorization form      

Tier 1

Tier 2

• diclofenac solution 0.1% (Voltaren®)
• flurbiprofen solution 0.03% (Ocufen®)
• ketorolac solution 0.5% (Acular®)  

• bromfenac 0.07% (Prolensa™)
• bromfenac (BromSite™) 0.075% solution
• Bromfenac 0.09%
• ketorolac solution (Acuvail®)
• ketorolac solution 0.4% (Acular LS®)
• nepafenac 0.3% (Ilevro™) 
• nepafenac 0.1% (Nevanac™)

Tier 1 products are covered with no authorization necessary

Tier 2 authorization criteria

• Documented trials of all Tier-1 ophthalmic corticosteroids (from different product lines) in the last 30 days that did not yield adequate relief of symptoms or resulted in intolerable adverse effects; OR
• Contraindication to all lower tiered medications; OR
• A unique indication for which the Tier-1 anti-inflammatories lack. 

 Prior Authorization form    

Tier 1

Tier 2

• Dexamethason Sodium Phosphate Solution 0.1%
• dexamethason suspension 0.1% (Maxidex™ )
• difluprednate emulsion 0.05% (Durezol®)
• fluorometholone suspension 0.1% (Flarex®, FML Liquifilm®)
• loteprednol suspension 0.5% (Lotemax®)
• prednisolone acetate suspension 1% (Omnipred®)
• prednisolon acetate suspension 0.12% (Pred Mild®)
• Prednisolone Sodium Phosphate Solution 1%
• rimexolone suspension 1% (Vexol®)

• fluorometholone ointment 0.1% (FML S.O.P®)
• fluorometholone suspension 0.25% (FML Forte®)
• loteprednol gel 0.5% (Lotemax®)
• loteprednol ointment 0.5% (Lotemax®)
• prednisolone acetate suspension (Pred Forte®)